FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases.
Sonoda, Junichiro
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. [electronic resource] - Hormone molecular biology and clinical investigation May 2017
Publication Type: Journal Article; Review
1868-1891
10.1515/hmbci-2017-0002 doi
Animals
Energy Metabolism--drug effects
Fibroblast Growth Factors--metabolism
Gene Expression Regulation--drug effects
Humans
Obesity--drug therapy
Protein Stability
Receptor, Fibroblast Growth Factor, Type 1--agonists
Signal Transduction--drug effects
Transcription, Genetic
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. [electronic resource] - Hormone molecular biology and clinical investigation May 2017
Publication Type: Journal Article; Review
1868-1891
10.1515/hmbci-2017-0002 doi
Animals
Energy Metabolism--drug effects
Fibroblast Growth Factors--metabolism
Gene Expression Regulation--drug effects
Humans
Obesity--drug therapy
Protein Stability
Receptor, Fibroblast Growth Factor, Type 1--agonists
Signal Transduction--drug effects
Transcription, Genetic